Results 91 to 100 of about 14,162 (232)

Hidradenitis Suppurativa and Post‐Arthroplasty Wound Complications

open access: yes
International Journal of Dermatology, EarlyView.
Dominique Digiacomo   +4 more
wiley   +1 more source

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis   +54 more
wiley   +1 more source

Near Circumferential Invasive Proliferative Gelatinous Mass in the Calf: An Unusual Presentation of Hidradenitis Suppurativa

open access: yesEuropean Medical Journal Dermatology, 2019
Hidradenitis suppurativa, or acne inversa, is a chronic, recurrent inflammatory disease of the skin and subcutaneous tissue, and is characterised by painful, recurrent nodules that results in abscesses and formation of chronic draining sinus tracts and ...
Shih Jia Janice Tan, Hsien Ts’ung Tay
doaj  

Short‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and NMA

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A meta‐analysis was conducted comparing the efficacy of biologics for the treatment of hidradenitis suppurativa (HS) for 12–16 weeks. Based on the SUCRA, bimekizumab was ranked the most efficacious treatment compared with secukinumab and adalimumab for all assessed efficacy outcomes, positioning it as the best treatment across biologic‐naïve and ...
Haley B. Naik   +9 more
wiley   +1 more source

Intermammary Hidradenitis Suppurativa [PDF]

open access: yesSkin Appendage Disorders, 2022
Philippe, Guillem   +1 more
openaire   +2 more sources

Cancer and hidradenitis suppurativa

open access: yesClinics in Dermatology
Patients with hidradenitis suppurativa (HS) have an increased risk of developing cancer. This includes not only hematologic malignancies and solid tumors but also cutaneous squamous cell carcinoma (SCC) originating within the HS lesions. The development of SCC is most commonly associated with Caucasian men who smoke and have severe gluteal or perianal ...
Philip R, Cohen   +2 more
openaire   +3 more sources

Disfiguring Hidradenitis Suppurativa of the Face [PDF]

open access: bronze, 2021
Gianmarco Capasso   +2 more
openalex   +1 more source

Long‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and MAIC

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A matching‐adjusted indirect treatment comparison (MAIC) was conducted, comparing approved biologics for long‐term (48–52 weeks) treatment of moderate‐to‐severe hidradenitis suppurativa (HS). Using weighted patient‐level trial data allowed re‐estimation of relative bimekizumab efficacy compared with aggregate secukinumab and adalimumab trial data ...
Thrasyvoulos Tzellos   +9 more
wiley   +1 more source

Skin Homeostasis is Impaired in Hidradenitis Suppurativa Lesions: A Comparative Study

open access: yesActas Dermo-Sifiliográficas
Introduction: Hidradenitis suppurativa (HS) is a chronic skin disease whose impact on skin homeostasis has not been adequately studied at present. Knowledge about how skin function changes in these patients, and could be of interest not only to improve ...
A. Soto-Moreno   +4 more
doaj   +1 more source

Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy [PDF]

open access: gold, 2022
Margaret M. Lowe   +15 more
openalex   +1 more source

Home - About - Disclaimer - Privacy